Skip to main content

Advertisement

Table 1 MSC clinical trials for immune-related diseases

From: Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

MSC source Total % Total No. No. of clinical trial phases
? 0 1 1 & 2 2 2 & 3 3 4
Unspecified 21.0 49 1 0 9 21 14 3 1 0
Bone marrow 41.2 96 3 1 21a 38 25 3 5 0
Adipose tissue 16.3 38 0 1 10 17 7 1 2 0
Umbilical cord 14.2 33 0 0 6ab 22 4c 0 0 1
Umbilical cord blood 5.6 13 0 0 3 4 3 1 2 0
Placenta 1.3 3 0 0 2b 0 1c 0 0 0
Menstrual Blood 0.4 1 0 0 0 1 0 0 0 0
Total No. of clinical trial phases   230 4 2 49d 103 53e 8 10 1
Total % of clinical trial phases    1.7 0.9 21.3 44.8 23.0 3.5 4.3 0.4
  1. abcMSCs are applied to the same clinical trials
  2. deNumber of total clinical trial phase 1 and phase 2 withdraw duplicated MSC source number in the same clinical trials